Navigation Links
Global Med Technologies(R), Inc. Receives FDA 510(K) Clearance for ElDorado Donor(TM)
Date:2/15/2008

DENVER, Feb. 15 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for ElDorado Donor(TM) a new blood management product produced by its Wyndgate Technologies(R) division ("Wyndgate"), paving the way for the Company to proceed marketing the product in the United States.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)

The ElDorado Donor release is the Company's next generation software and is intended as a comprehensive blood management software application created to provide for the information system needs of blood bank and donor centers. The software is designed to manage, automate, and control activities associated with donors, donor collections, testing, manufacturing, inventory, and distribution. ElDorado Donor was developed with scalability in mind and is designed to manage the system needs of diverse facilities, from small hospital blood banks to community blood centers, to regional and national centers. The release marks a new growth opportunity for the Company both domestically and internationally.

Utilizing an integrated modular configuration, ElDorado Donor is intended to offer functionality with flexibility to tailor features within the system to a facility's specific needs supporting process control from collection to distribution. The software was created for ease-of-use which includes drop down lists and easy access "find" forms. Wyndgate's At-a-Glance(TM) bars provide visual indications of the presence of relevant information offering quick and easy access to that information. ElDorado Donor is designed to support the industry standard for labeling (ISBT128), as well as the ABC Codabar blood product labeling standard.

ElDora
'/>"/>

SOURCE Global Med Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Global Med Technologies(R), Inc. Recieves FDA 510(K) Clearance for ElDorado Donor(TM)
2. New study shows extent of harmful human influences on global ecosystems
3. Jill Birkett Appointed Event Director for HBA Global Expo
4. Companion Global Healthcare Adds Hospital in Costa Rica to Overseas Network
5. Opportunities to Invest in Puerto Rico as Global Center for Biotechnology
6. Audience Selected as One of Two Finalists for Most Innovative True Mobile Start-Up for the 2008 GSMA Mobile Innovation Global Awards
7. Covance to Present at UBS Global Healthcare Services Conference
8. AIDS Healthcare Foundation Shares World Bank, Global Fund Concerns Over Alleged Corruption at Indias NACO
9. Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program
10. Congress Poised to Reauthorize Legislation Aimed at Dramatic Expansion of Global HIV and AIDS Programs
11. CorVel to Present at UBS Global Healthcare Services Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...t their response to a "cocaine-cues" video, active...s activity in brain regions linked to drug craving...of Energy,s Brookhaven National Laboratory. The re...uroImage , suggest that clinical interventions des...ld help cocaine abusers stop using drugs and avoid...
(Date:11/30/2009)...nd dessert at the holiday table are even less of a...ccording to a new research report recently appeari...bj.org ), a diet that is high in fat and in sugar ...ur bodies to store too much fat. This means these ...difficult task of converting high-fat and high-sug...
(Date:11/30/2009)...avily more often than younger people, study finds,...- Older people who are problem drinkers consume mo...report finds, possibly because they need more alco... a study released this month, people dependent on ... drinks a week, on average. By contrast, younger a...
(Date:11/30/2009).... Rappa, MD, explores the intricate connection bet...ealing Heart to Soul: One Doctor’s Journey o...9). , Dallas, TX (Vocus) ... let go of negative emotions, whether caused by us...oulders. Oftentimes, this disease of the human spi...
(Date:11/30/2009)..., Nov. 30 Baxa Corporation is spon... "culture of safety" means in today,s pharmacy env...eating a Culture of Safety in Pharmacy ," features... their experiences with culture of safety, what it...d the role of technology in enabling or inhibiting...
Breaking Medicine News(10 mins):Health News:Brain scan study shows cocaine abusers can control cravings 2Health News:Brain scan study shows cocaine abusers can control cravings 3Health News:Western diets turn on fat genes 2Health News:Binge Drinking Not Just a Rite of the Young 2Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3
..., Rockville, Md., September 24, 2008 The U.S. Ph...e the release of its first Certified Reference Mat...cently became the first global pharmacopeia to rec... with a new class of reference standard that ensur...
..., The depth of transmural tumor invasion along th...al lymph nodes constitute major factors in the pro...rative staging of rectal cancer carries a crucial ...rated well in the literature. However, studies com...
..., Black Americans have a higher occurrence of col...nificant finding considering the incidence of colo...d unchanged among black women during the last 20 y...d A. Lieberman, M.D., head of gastroenterology, Or...
...Pioneer of concierge medicine selects finest local...cago practice, BELLEVUE, Wash., Sept. 24 MD2 Int...ned a Chicago practice with two of the,area,s fine...hysicians and expand its network., "Many of the f...
...Panel of ALS Researchers to Present and Consider t...., Sept. 24 The ALS Therapy,Development Institute...annual ALS research symposium, part of the fourth ...cientists will provide,presentations on the develo...
...Deal Marks First High-Definition Interactive Syste...thcare Facility Deployment, SIOUX FALLS, S.D., Se...t Interactive Corporation (Nasdaq: LNET ),announc...sity HealthSystem facilities in the Chicago area. ...
Other Medicine News:Health News:Which is more accurate on diagnosis of rectal carcinoma? 2Health News:Black Americans are at higher risk for colon polyps 2Health News:MD2 International Brings Highly Attentive Medicine to Chicago 2Health News:ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit 2Health News:ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit 3Health News:ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit 4Health News:LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 2Health News:LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 3
(Date:11/30/2009)... , , INDIANAPOLIS, Nov. 30 /PRNew...tration (FDA) has approved Cymbalta® (duloxet...zed anxiety disorder (GAD) in adults, Eli Lilly an...ince generalized anxiety disorder can be a chronic...atients find a treatment option that is effective ...
(Date:11/30/2009)... , , THOUSAND OAKS, Calif., Nov. 30 /PR... today announced that it will present updated long...omiplostim) in adult chronic immune (idiopathic) t... will present the first Nplate study in a pediatri...tic syndromes (MDS) at the 2009 American Society o...
(Date:11/29/2009)... , , CHICAGO, Nov. 30 Rad...is from a remote location with the use of a handhe...ftware, according to a study presented today at th...rth America (RSNA). ,, "The goal is to improve...ell as to improve communications among different c...
Breaking Medicine Technology:FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5Amgen Highlights Data to be Presented at ASH 2Amgen Highlights Data to be Presented at ASH 3Amgen Highlights Data to be Presented at ASH 4Amgen Highlights Data to be Presented at ASH 5Amgen Highlights Data to be Presented at ASH 6Amgen Highlights Data to be Presented at ASH 7Amgen Highlights Data to be Presented at ASH 8Amgen Highlights Data to be Presented at ASH 9Amgen Highlights Data to be Presented at ASH 10Amgen Highlights Data to be Presented at ASH 11Smart Phones Allow Quick Diagnosis of Acute Appendicitis 2Smart Phones Allow Quick Diagnosis of Acute Appendicitis 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 1LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 2LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 1SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 2SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 3SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 5PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 1PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 2
..., Fla. , May 29 GlaxoSmithKline [NYSE: GSK] and ...ted States Food and Drug Administration,s (FDA) On...o three that the ARZERRA(TM) (ofatumumab) data are... patients with chronic lymphocytic leukemia (CLL) ...mtuzumab. Ofatumumab is an investigational treatme...
...VILLE, Pa., May 29 Wyeth Pharmaceuticals, a divis...minary data from two ongoing studies, one evaluati...umab (Herceptin(R), Roche) in HER-2 positive (ErbB...nvestigating neratinib safety and efficacy when gi...b) in patients with HER-2 dependent solid tumors. ...
Other Medicine Technology:FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 2FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 3FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 4FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 5New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 2New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 3New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 4New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 5
7121B Sony Medical Monitor
...ompletely new and revolutionary lens system. The u... size without distortion. The 115 field of view su...tion of the telescope. Beyond that a new quick loc... is introduced. It is the combination of outstandi...
...e the surgeon with an optimal work area and reduce...t and retinal surgery. Perfect Pupil Injectable is...pils which allows expansion of the pupil to 8mm co...gery, and allows the pupil to return to its normal...
Defiant 95% Bag Filter
Medicine Products: